MICAD adds 23 new agents

Justine Varieur Cadet | | Health Imaging | Molecular Imaging
The Molecular Imaging and Contrast Agent Database (MICAD) program, which is designed to foster research and development in molecular imaging by providing free online scientific information regarding in vivo molecular imaging and contrast agents, has added 23 agents to its roster.

The new agents are:

PET agents:
  • [11C]A-844606 Target: Neuronal a7 nicotinic acetylcholine receptor (nAChR)
  • [11C]A-582941 Target: nAChR
  • [11C]A-836339 Target: Cannabinoid CB2 receptors
  • [18F]FP-OSP-1 Target: Heparan sulfate proteoglycans (HSPG)
  • [18F]6b Target: Gastrin-releasing peptide receptor (GRPR)
  • [18F]7b Target: GRPR
  • [18F]NS10743 Target: nAChR
  • anti-2-[18F]FACBC Target: L-type amino acid transporter
  • syn-3-[18F]FACBC Target: L-type amino acid transporter
  • anti-2-[18F]FACPC Target: L-type and A-type amino acid transporters
  • 64Cu-NO2A-(9-Anc)-BBN(7–14)NH2 Target: GRPR
  • 64Cu-NO2A-(AMBA)-BBN(7–14)NH2 Target: GRPR
  • 64Cu-NO2A-(6-Ahx)-BBN(7–14)NH2 Target: Gastrin-GRPR
  • [68Ga]6 Target: Prostate-specific membrane antigen (PSMA)
  • 68Ga-AM3 Target: Somatostatin receptors (SSTRs)
  • 89Zr-Df-R1507 Target: Insulin-like growth factor 1 receptor (IGF-1R)
 
SPECT agents:
  • [99mTc(CO)3]+-(HE)3-ZHER2:342 Target: Epidermal growth factor receptor (HER2)
  • [99mTc(CO)3]+-ZHER2:342-H6 Target: HER2
  • [99mTc(CO)3]+-H6-ZHER2:342 Target: HER2
  • 111In-DTPA-R1507 Target: IGF-1R
  • 177Lu-AM3 Target: SSTRs
 
MRI agents:
  • BM3h-8C8 Target: Dopamine
 
Multimodality agents:
  • 64Cu-DOTA/Cy5.5-2.5D Target: avB3, ?vB5, and ?5B1 integrin receptors
 
The comprehensive list—with 952 agents and approximately 4,000 imaging probes—is now available at the MICAD database.

Justine Varieur Cadet

Related Content

Repurposed radiotracer lights up treatment-resistant tumors 'like a Christmas tree'
Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.